HYCAMTIN (Novartis Pharmaceuticals Corporation)
Welcome to the PulseAid listing for the HYCAMTIN drug offered from Novartis Pharmaceuticals Corporation. This Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Novartis Pharmaceuticals Corporation |
| NON-PROPRIETARY NAME: | topotecan |
| SUBSTANCE NAME: | TOPOTECAN HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2017-07-07 |
| END MARKETING DATE: | 0000-00-00 |
HYCAMTIN HUMAN PRESCRIPTION DRUG Details:
| Item Description | HYCAMTIN from Novartis Pharmaceuticals Corporation |
| LABELER NAME: | Novartis Pharmaceuticals Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 0.25(mg/1) |
| START MARKETING DATE: | 2017-07-07 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0078-0672_221854df-9a47-444a-98c8-2f77c370df1c |
| PRODUCT NDC: | 0078-0672 |
| APPLICATION NUMBER: | NDA020981 |
Other TOPOTECAN HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
